1. Home
  2. EVTC vs MLTX Comparison

EVTC vs MLTX Comparison

Compare EVTC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$27.35

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$19.90

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
MLTX
Founded
1988
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
EVTC
MLTX
Price
$27.35
$19.90
Analyst Decision
Hold
Buy
Analyst Count
5
12
Target Price
$35.80
$27.50
AVG Volume (30 Days)
715.8K
1.2M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
N/A
EPS
0.38
N/A
Revenue
$453,869,000.00
N/A
Revenue This Year
$12.68
N/A
Revenue Next Year
$6.86
N/A
P/E Ratio
$69.16
N/A
Revenue Growth
11.48
N/A
52 Week Low
$21.81
$5.95
52 Week High
$37.79
$62.75

Technical Indicators

Market Signals
Indicator
EVTC
MLTX
Relative Strength Index (RSI) 60.55 55.27
Support Level $25.39 $15.54
Resistance Level $30.05 $21.00
Average True Range (ATR) 1.22 1.18
MACD 0.31 0.12
Stochastic Oscillator 81.86 44.20

Price Performance

Historical Comparison
EVTC
MLTX

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: